SELLAS Life Sciences Group, Inc. Payments for Repurchase of Warrants
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- SELLAS Life Sciences Group, Inc. payments for repurchase of warrants for the quarter ending 2013-06-30 was $0.00.
- SELLAS Life Sciences Group, Inc. payments for repurchase of warrants for the quarter ending 2013-03-31 was $0.00.
- SELLAS Life Sciences Group, Inc. payments for repurchase of warrants for the quarter ending 2012-12-31 was $0.00.
- SELLAS Life Sciences Group, Inc. payments for repurchase of warrants for the quarter ending 2012-09-30 was $0.00.
| Period end | Payments for Repurchase of Warrants 3 month | Payments for Repurchase of Warrants 12 month |
|---|---|---|
| 2013-06-30 | $0.00 derived: 10-Q 126 month − 10-Q 123 month · filed 2013-08-09 | $0.00 derived: sum of 4 quarters · filed 2015-12-04 |
| 2013-03-31 | $0.00 derived: 10-Q 123 month − 10-K 120 month · filed 2013-05-09 | |
| 2012-12-31 | $0.00 derived: 8-K 12 month − 10-Q/A 9 month · filed 2015-12-04 | $266.00K 8-K · filed 2015-12-04 |
| 2012-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |